Wingrove Theresa's most recent trade in Immunogen, Inc. was a trade of 187,667 Common Stock done at an average price of $29.6 . Disclosure was reported to the exchange on Jan. 16, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Sale of securities on an exchange or to another person at price $ 29.64 per share. | 16 Jan 2024 | 187,667 | 3,426 (0%) | 0% | 29.6 | 5,562,450 | Common Stock |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 126,100 | 0 | - | - | Stock Option (Right to Buy) | |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.25 per share. | 16 Jan 2024 | 126,100 | 191,093 (0%) | 0% | 5.3 | 662,025 | Common Stock |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.83 per share. | 16 Jan 2024 | 58,900 | 62,326 (0%) | 0% | 4.8 | 284,487 | Common Stock |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 58,900 | 0 | - | - | Stock Option (right to buy) | |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.75 per share. | 16 Jan 2024 | 2,667 | 64,993 (0%) | 0% | 5.7 | 15,335 | Common Stock |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2024 | 2,667 | 1,333 | - | - | Stock Option (right to buy) | |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 16.01 per share. | 29 Dec 2023 | 615 | 3,426 (0%) | 0% | 16.0 | 9,846 | Common Stock |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Sale of securities on an exchange or to another person at price $ 29.40 per share. | 15 Dec 2023 | 117,445 | 2,811 (0%) | 0% | 29.4 | 3,452,883 | Common Stock |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 89,657 | 115,273 | - | - | Stock Option (right to buy) | |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.32 per share. | 15 Dec 2023 | 89,657 | 120,256 (0%) | 0% | 5.3 | 476,975 | Common Stock |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.55 per share. | 15 Dec 2023 | 27,788 | 30,599 (0%) | 0% | 4.5 | 126,435 | Common Stock |
| Immunogen Inc | Wingrove Theresa | SVP OF REGULATORY AFFAIRS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 27,788 | 35,871 | - | - | Stock Option (right to buy) | |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 4.05 per share. | 30 Jun 2023 | 2,811 | 86,156 (0%) | 0% | 4.1 | 11,385 | Common Stock |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 140,400 | 140,400 | - | - | Stock Option (right to buy) | |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 54,600 | 54,600 | - | - | Restricted Stock Unit | |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 23,400 | 23,400 | - | - | Restricted Stock Unit | |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 3.92 per share. | 30 Dec 2022 | 1,131 | 83,345 (0%) | 0% | 3.9 | 4,434 | Common Stock |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 3.82 per share. | 30 Jun 2022 | 2,645 | 82,214 (0%) | 0% | 3.8 | 10,117 | Common Stock |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 166,725 | 250,088 | - | - | Stock Option (Right to Buy) | |
| Immunogen Inc | Theresa Wingrove | SVP OF REGULATORY AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 83,363 | 83,363 | - | - | Stock Option (Right to Buy) | |
| Immunogen Inc | Theresa Wingrove | SVP, Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 204,930 | 204,930 | - | - | Common Stock (right to buy) | |
| Immunogen Inc | Theresa Wingrove | SVP of Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 5.52 per share. | 30 Jun 2021 | 1,768 | 77,518 (0%) | 0% | 5.5 | 9,759 | Common Stock |
| Immunogen Inc | Theresa Wingrove | SVP of Regulatory Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 121,905 | 121,905 | - | - | Common Stock (right to buy) |